Cargando…
Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis
BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857375/ https://www.ncbi.nlm.nih.gov/pubmed/31742141 http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19 |
_version_ | 1783470759535968256 |
---|---|
author | Charan, Jaykaran Tank, Nitish Reljic, Tea Singh, Surjit Bhardwaj, Pankaj Kaur, Rimplejeet Goyal, Jagdish P. Kumar, Ambuj |
author_facet | Charan, Jaykaran Tank, Nitish Reljic, Tea Singh, Surjit Bhardwaj, Pankaj Kaur, Rimplejeet Goyal, Jagdish P. Kumar, Ambuj |
author_sort | Charan, Jaykaran |
collection | PubMed |
description | BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult patients in India. METHODS: PubMed and Google Scholar were searched to find different observational studies reporting MDR-TB prevalence in India. Data related to MDR-TB prevalence were pooled for the analysis. PubMed was searched by using different MeSH words. Prevalence was reported with 95% confidence interval (CI). A separate analysis was done for new cases and previously treated cases. Random effect model was used and heterogeneity was assessed by I(2) and Cochran Q test. RESULTS: MDR-TB prevalence in new cases were 3% (95% CI 2%-5%, I(2) = 95.3%). There was difference in prevalence between different methods of measurement of MDR-TB and study designs. MDR-TB prevalence in previously treated cases was found to be 35% (95% CI 29%-41%, I(2) = 98.7%). Results vary with the method of measurement as well as the study design. CONCLUSION: MDR-TB prevalence in previously treated patients was found higher compared to the reported values in national surveys. There is a need for large scale cross-sectional study to verify the findings observed in this review. |
format | Online Article Text |
id | pubmed-6857375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-68573752019-11-18 Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis Charan, Jaykaran Tank, Nitish Reljic, Tea Singh, Surjit Bhardwaj, Pankaj Kaur, Rimplejeet Goyal, Jagdish P. Kumar, Ambuj J Family Med Prim Care Original Article BACKGROUND: Multidrug resistance tuberculosis (MDR-TB) is an important public health problem for India but there is a paucity of data related to the prevalence of MDR-TB in India. This systematic review and meta-analysis was designed to synthesize evidence regarding the prevalence of MDR-TB in adult patients in India. METHODS: PubMed and Google Scholar were searched to find different observational studies reporting MDR-TB prevalence in India. Data related to MDR-TB prevalence were pooled for the analysis. PubMed was searched by using different MeSH words. Prevalence was reported with 95% confidence interval (CI). A separate analysis was done for new cases and previously treated cases. Random effect model was used and heterogeneity was assessed by I(2) and Cochran Q test. RESULTS: MDR-TB prevalence in new cases were 3% (95% CI 2%-5%, I(2) = 95.3%). There was difference in prevalence between different methods of measurement of MDR-TB and study designs. MDR-TB prevalence in previously treated cases was found to be 35% (95% CI 29%-41%, I(2) = 98.7%). Results vary with the method of measurement as well as the study design. CONCLUSION: MDR-TB prevalence in previously treated patients was found higher compared to the reported values in national surveys. There is a need for large scale cross-sectional study to verify the findings observed in this review. Wolters Kluwer - Medknow 2019-10-31 /pmc/articles/PMC6857375/ /pubmed/31742141 http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19 Text en Copyright: © 2019 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Charan, Jaykaran Tank, Nitish Reljic, Tea Singh, Surjit Bhardwaj, Pankaj Kaur, Rimplejeet Goyal, Jagdish P. Kumar, Ambuj Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title | Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title_full | Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title_fullStr | Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title_full_unstemmed | Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title_short | Prevalence of multidrug resistance tuberculosis in adult patients in India: A systematic review and meta-analysis |
title_sort | prevalence of multidrug resistance tuberculosis in adult patients in india: a systematic review and meta-analysis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857375/ https://www.ncbi.nlm.nih.gov/pubmed/31742141 http://dx.doi.org/10.4103/jfmpc.jfmpc_542_19 |
work_keys_str_mv | AT charanjaykaran prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT tanknitish prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT reljictea prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT singhsurjit prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT bhardwajpankaj prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT kaurrimplejeet prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT goyaljagdishp prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis AT kumarambuj prevalenceofmultidrugresistancetuberculosisinadultpatientsinindiaasystematicreviewandmetaanalysis |